CPO assay gets CE mark, 3/18
March 2018—Becton Dickinson and Check-Points obtained the CE mark for a next-generation molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the BD Max System.
Webinars and Sponsored Roundtables — Register Now
Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Fabric Genomics expanded somatic cancer solution, 3/18
March 2018—Fabric Genomics announced its expanded somatic cancer solution at the 2017 Association for Molecular Pathology annual meeting in November. The solution provides genomic analysis and clinical reporting to clinical labs and enables therapy matching for cancer patients, giving clinicians targeted treatment choices. It offers one integrated platform for the interpretation of somatic cancer panels, hereditary panels, and whole genomes.
FDA-cleared respiratory infection assay, 3/18
March 2018—Quidel has received clearance from the FDA to market its Solana respiratory syncytial virus plus human metapneumovirus assay for the detection of nucleic acids isolated from nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection to aid in the diagnosis of RSV and/or hMPV infections.
Biotin interference educational website, 3/18
March 2018—Roche Diagnostics has introduced the biotinfacts.roche.com website to provide laboratorians with up-to-date data on and best practices for biotin interference. The website offers laboratorians information and answers needed to mitigate risk and help ensure patient safety.
CE-IVD mark for PlexPCR VHS test, 2/18
February 2018—SpeeDx announced it has received CE-IVD marking for its PlexPCR VHS multiplex qPCR test. The test offers a single-well solution to cover the detection and differentiation of the main causes of genital and oral lesions—herpes simplex virus types 1 and 2, Treponema pallidum (syphilis), and varicella zoster virus.
Apoptotic cell-free DNA amplification kit, 2/18
February 2018—Sygnis, based in Heidelberg, Germany, announced the launch of its TruePrime Apoptotic Cell-Free DNA Amplification Kit, under its Expedeon brand. The kit enables accurate DNA amplification using cfDNA obtained from plasma, serum, urine, cerebrospinal fluid, and other bodily fluids.
Sterile vacuum filtration system, 2/18
February 2018—MilliporeSigma launched the Stericup Quick Release 500 mL vacuum filtration system, a filter bottle system for sterile filtration of cell culture media, buffers, and reagents.
DNA purification reagents, 2/18
February 2018—Thermo Fisher Scientific released its MagMax DNA Multi-Sample Ultra 2.0 reagents, which provide genetic testing companies, labs, and service providers with high-throughput DNA extraction from blood, saliva, buffy coat, and buccal swabs. The next-generation reagents can purify DNA from 96 samples in 45 minutes on Thermo Scientific KingFisher instruments using a simplified protocol for either small- or large-volume sample input.
Remote mobile microscope, 2/18
February 2018—Spot Imaging introduced its CytoXpress, an FDA-approved consultation method that lets clinicians and technologists transmit a live, interactive image stream directly to the user’s computer, eliminating the travel and wait time associated with on-site consults.
Autofluorescence quenching reagent, 2/18
February 2018—Vector Laboratories introduced the TrueView Autofluorescence Quenching Kit for removing unwanted fluorescence in formalin-fixed, paraffin-embedded tissue samples, blood cells, and structural elements such as collagen and elastin.